Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.

Prokaryotic adaptive immune systems use Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) and CRISPR-associated (Cas) proteins for RNA-guided cleavage of foreign genetic elements. The focus of this review, Type VI CRISPR-Cas systems, contain a single protein, Cas13 (formerly C2c2) that when assembled with a CRISPR RNA (crRNA) forms a crRNA-guided RNA-targeting effector complex. Type VI CRISPR-Cas systems can be divided into four subtypes (A-D) based on Cas13 phylogeny. All Cas13 proteins studied to date possess two enzymatically distinct ribonuclease activities that are required for optimal interference. One RNase is responsible for pre-crRNA processing to form mature Type VI interference complexes, while the other RNase activity provided by the two Higher Eukaryotes and Prokaryotes Nucleotide-binding (HEPN) domains, is required for degradation of target-RNA during viral interference. In this review, I will compare and contrast what is known about the molecular architecture and behavior of Type VI (A-D) CRISPR-Cas13 interference complexes, how this allows them to carry out their RNA-targeting function, how Type VI accessory proteins are able to modulate Cas13 activity, and how together all of these features have led to the rapid development of a range of RNA-targeting applications. Throughout I will also discuss some of the outstanding questions regarding Cas13's molecular behavior, and its role in bacterial adaptive immunity and RNA-targeting applications.

[1]  K. Datsenko,et al.  The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system , 2015, Nucleic acids research.

[2]  Dmitry Lyumkis,et al.  Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d , 2018, Cell.

[3]  A. Regev,et al.  Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System , 2015, Cell.

[4]  Jennifer A. Doudna,et al.  Structures of Cas9 Endonucleases Reveal RNA-Mediated Conformational Activation , 2014, Science.

[5]  Stan J. J. Brouns,et al.  Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes , 2008, Science.

[6]  Kira S. Makarova,et al.  Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL domain-containing accessory protein , 2018, Molecular cell.

[7]  Zhicong Chen,et al.  Targeting cellular mRNAs translation by CRISPR-Cas9 , 2016, Scientific Reports.

[8]  M. F. White,et al.  CARF and WYL domains: ligand-binding regulators of prokaryotic defense systems , 2014, Front. Genet..

[9]  Oscar A. Negrete,et al.  RNA-dependent RNA targeting by CRISPR-Cas9 , 2018, eLife.

[10]  Alexander Bolotin,et al.  Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. , 2005, Microbiology.

[11]  Feng Zhang,et al.  Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA , 2014, Cell.

[12]  Jennifer A. Doudna,et al.  Programmable RNA Tracking in Live Cells with CRISPR/Cas9 , 2016, Cell.

[13]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[14]  R. Barrangou,et al.  CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes , 2007, Science.

[15]  Sita J. Saunders,et al.  An Active Immune Defense with a Minimal CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) RNA and without the Cas6 Protein* , 2014, The Journal of Biological Chemistry.

[16]  Luciano A. Marraffini,et al.  Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity , 2015, Cell.

[17]  Philippe Horvath,et al.  The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli , 2011, Nucleic acids research.

[18]  J. Doudna,et al.  Programmable RNA recognition using a CRISPR-associated Argonaute , 2017, Proceedings of the National Academy of Sciences.

[19]  Aviv Regev,et al.  RNA targeting with CRISPR–Cas13 , 2017, Nature.

[20]  Aviv Regev,et al.  Nucleic acid detection with CRISPR-Cas13a/C2c2 , 2017, Science.

[21]  G. Montoya,et al.  Allosteric regulation of Csx1, a type IIIB-associated CARF domain ribonuclease by RNAs carrying a tetraadenylate tail , 2017, Nucleic acids research.

[22]  J. Doudna,et al.  RNA-guided genetic silencing systems in bacteria and archaea , 2012, Nature.

[23]  E. Charpentier,et al.  Adaptation in CRISPR-Cas Systems. , 2016, Molecular cell.

[24]  Dipali G Sashital.  Pathogen detection in the CRISPR–Cas era , 2018, Genome Medicine.

[25]  Jennifer A. Doudna,et al.  RNA-based recognition and targeting: sowing the seeds of specificity , 2017, Nature Reviews Molecular Cell Biology.

[26]  J. Oost,et al.  Unravelling the structural and mechanistic basis of CRISPR–Cas systems , 2014, Nature Reviews Microbiology.

[27]  Eugene V Koonin,et al.  CRISPR-Cas , 2013, RNA biology.

[28]  Gaetano T Montelione,et al.  Crystal structure of RlmAI: Implications for understanding the 23S rRNA G745/G748-methylation at the macrolide antibiotic-binding site , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Terns,et al.  The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease , 2016, RNA.

[30]  Luciano A. Marraffini,et al.  Genetic Characterization of Antiplasmid Immunity through a Type III-A CRISPR-Cas System , 2013, Journal of bacteriology.

[31]  Ceslovas Venclovas,et al.  Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus. , 2014, Molecular cell.

[32]  E. Koonin,et al.  Comprehensive analysis of the HEPN superfamily: identification of novel roles in intra-genomic conflicts, defense, pathogenesis and RNA processing , 2013, Biology Direct.

[33]  B. Graveley,et al.  RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex , 2009, Cell.

[34]  Kira S. Makarova,et al.  SnapShot: Class 2 CRISPR-Cas Systems , 2017, Cell.

[35]  J. Doudna,et al.  Guide-bound structures of an RNA-targeting A-cleaving CRISPR–Cas13a enzyme , 2017, Nature Structural &Molecular Biology.

[36]  Stan J. J. Brouns,et al.  Evolution and classification of the CRISPR–Cas systems , 2011, Nature Reviews Microbiology.

[37]  M. Moore,et al.  Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of Its Nucleic Acid Guides , 2015, Cell.

[38]  S. Konermann,et al.  Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors , 2018, Cell.

[39]  B. Oh,et al.  Crystal structure and nucleic acid‐binding activity of the CRISPR‐associated protein Csx1 of Pyrococcus furiosus , 2013, Proteins.

[40]  Yanli Wang,et al.  Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities , 2017, Cell.

[41]  J. García-Martínez,et al.  Short motif sequences determine the targets of the prokaryotic CRISPR defence system. , 2009, Microbiology.

[42]  Gene W. Yeo,et al.  Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9 , 2017, Cell.

[43]  Jennifer A. Doudna,et al.  Conformational control of DNA target cleavage by CRISPR–Cas9 , 2015, Nature.

[44]  Max J. Kellner,et al.  RNA editing with CRISPR-Cas13 , 2017, Science.

[45]  J. García-Martínez,et al.  Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements , 2005, Journal of Molecular Evolution.

[46]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[47]  J. Doudna,et al.  The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.

[48]  D. Burstein,et al.  RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes. , 2017, Molecular cell.

[49]  J. Mackay,et al.  The prospects for designer single-stranded RNA-binding proteins , 2011, Nature Structural &Molecular Biology.

[50]  J. Donovan,et al.  Rapid RNase L–driven arrest of protein synthesis in the dsRNA response without degradation of translation machinery , 2017, RNA.

[51]  Kira S. Makarova,et al.  Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis , 2018, Proceedings of the National Academy of Sciences.

[52]  B. Voß,et al.  Adaptation and modification of three CRISPR loci in two closely related cyanobacteria , 2013, RNA biology.

[53]  Eugene V Koonin,et al.  Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems , 2011, Biology Direct.

[54]  Eugene V Koonin,et al.  Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems. , 2015, Molecular cell.

[55]  Wei Yang,et al.  Nucleases: diversity of structure, function and mechanism , 2010, Quarterly Reviews of Biophysics.

[56]  Jennifer A. Doudna,et al.  Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering , 2016, Cell.

[57]  Wei Wang,et al.  Human RNase L tunes gene expression by selectively destabilizing the microRNA-regulated transcriptome , 2015, Proceedings of the National Academy of Sciences.

[58]  R. Barrangou,et al.  Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria , 2012, Proceedings of the National Academy of Sciences.

[59]  Ahmed Mahas,et al.  RNA virus interference via CRISPR/Cas13a system in plants , 2017, Genome Biology.

[60]  Jun Ma,et al.  The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a , 2017, Cell.

[61]  D. C. Swarts,et al.  Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a. , 2017, Molecular cell.

[62]  James J. Collins,et al.  Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6 , 2018, Science.

[63]  Thorsten Bischler,et al.  CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9. , 2018, Molecular cell.

[64]  Akshay Tambe,et al.  RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a. , 2018, Cell reports.

[65]  Kira S. Makarova,et al.  Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA , 2016, Cell.

[66]  Frank Schwede,et al.  Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers , 2017, Nature.

[67]  Kira S. Makarova,et al.  Diversity and evolution of class 2 CRISPR–Cas systems , 2017, Nature Reviews Microbiology.

[68]  Ines Fonfara,et al.  The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA , 2016, Nature.

[69]  Kira S. Makarova,et al.  Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems , 2016, Science.

[70]  Eugene V Koonin,et al.  Diversity, classification and evolution of CRISPR-Cas systems. , 2017, Current opinion in microbiology.

[71]  J. Donovan,et al.  Structure of Human RNase L Reveals the Basis for Regulated RNA Decay in the IFN Response , 2014, Science.

[72]  R. Bertram,et al.  Toxin-antitoxin systems are ubiquitous and versatile modulators of prokaryotic cell fate. , 2013, FEMS microbiology letters.

[73]  P. Zamore,et al.  Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties. , 2012, Cell.

[74]  Jennifer A. Doudna,et al.  New CRISPR-Cas systems from uncultivated microbes , 2016, Nature.

[75]  Kira S. Makarova,et al.  SnapShot: Class 1 CRISPR-Cas Systems , 2017, Cell.

[76]  E. Koonin,et al.  Coupling immunity and programmed cell suicide in prokaryotes: Life‐or‐death choices , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.

[77]  Erik J. Sontheimer,et al.  Self vs. non-self discrimination during CRISPR RNA-directed immunity , 2009, Nature.

[78]  K. Heuner,et al.  First indication for a functional CRISPR/Cas system in Francisella tularensis. , 2013, International journal of medical microbiology : IJMM.

[79]  Gene W. Yeo,et al.  Reversal of molecular pathology by RNA-targeting Cas9 in a myotonic dystrophy mouse model , 2017, bioRxiv.

[80]  Philippe Horvath,et al.  The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA , 2010, Nature.

[81]  Albert J R Heck,et al.  RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus. , 2014, Molecular cell.

[82]  Eric S. Lander,et al.  C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector , 2016, Science.

[83]  Benjamin L. Oakes,et al.  Programmable RNA recognition and cleavage by CRISPR/Cas9 , 2014, Nature.

[84]  Yan Zhang,et al.  Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis. , 2018, Molecular cell.

[85]  Daphne A. Cooper,et al.  Ribonuclease L and metal-ion–independent endoribonuclease cleavage sites in host and viral RNAs , 2014, Nucleic acids research.

[86]  Jing Zhang,et al.  Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. , 2012, Molecular cell.

[87]  G. Vergnaud,et al.  CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. , 2005, Microbiology.

[88]  Shiraz A Shah,et al.  CRISPR adaptive immune systems of Archaea , 2014, RNA biology.

[89]  F. Sicheri,et al.  Structure of the Dual Enzyme Ire1 Reveals the Basis for Catalysis and Regulation in Nonconventional RNA Splicing , 2008, Cell.

[90]  A. Alladin,et al.  The WYL Domain of the PIF1 Helicase from the Thermophilic Bacterium Thermotoga elfii is an Accessory Single-Stranded DNA Binding Module. , 2018, Biochemistry.

[91]  Jennifer A. Doudna,et al.  Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection , 2016, Nature.

[92]  Joshua R. Elmore,et al.  Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs. , 2012, Molecular cell.

[93]  R. Terns,et al.  Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complex , 2014, Genes & development.

[94]  Sita J. Saunders,et al.  An updated evolutionary classification of CRISPR–Cas systems , 2015, Nature Reviews Microbiology.

[95]  Česlovas Venclovas,et al.  A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems , 2017, Science.

[96]  M. Jinek,et al.  Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6 , 2016, RNA.

[97]  Ningning Li,et al.  The crystal structure of Cpf1 in complex with CRISPR RNA , 2016, Nature.

[98]  Sergey A. Shmakov,et al.  Cas13b is a Type VI-B CRISPR-associated RNA-Guided RNase differentially regulated by accessory proteins Csx27 and Csx28 , 2016, bioRxiv.

[99]  R. Silverman,et al.  Dimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral Activity , 2014, Molecular Cell.

[100]  Megan L Hochstrasser,et al.  Cutting it close: CRISPR-associated endoribonuclease structure and function. , 2015, Trends in biochemical sciences.

[101]  B. Wiedenheft,et al.  Conformational regulation of CRISPR-associated nucleases. , 2017, Current opinion in microbiology.

[102]  J. Vogel,et al.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III , 2011, Nature.